Back to Search
DR. MARK R CRUMP MD
MD
Family Medicine Physician
NPI: 1578530366Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
R3938(AR)
Research & Publications (20)
The flexibility of context-specific control: evidence for context-driven generalization of item-specific control settings.
PMID 19370487·Q J Exp Psychol (Hove)·2009
8-other
Context-specific learning and control: the roles of awareness, task relevance, and relative salience.
PMID 17349805·Conscious Cogn·2008
2-rct
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
PMID 18025439·J Clin Oncol·2008
4-observational
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma.
PMID 18296419·Ann Oncol·2008
3-trial
Management of Hodgkin lymphoma in relapse after autologous stem cell transplant.
PMID 19074105·Hematology Am Soc Hematol Educ Program·2008
8-other
A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150.
PMID 16971665·Ann Oncol·2007
3-trial
What is the role of rituximab in salvage treatment for patients with diffuse large B-cell lymphoma?
PMID 17169786·Leuk Lymphoma·2006
8-other
The context-specific proportion congruent Stroop effect: location as a contextual cue.
PMID 16893001·Psychon Bull Rev·2006
8-other
A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma.
PMID 15989710·Clin Lymphoma·2005
3-trial
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).
PMID 15386331·Cancer·2004
3-trial
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
PMID 12915595·J Clin Oncol·2003
4-observational
Inhibition of raf kinase in the treatment of acute myeloid leukemia.
PMID 12369851·Curr Pharm Des·2002
6-review
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study.
PMID 12400600·Leuk Lymphoma·2002
3-trial
Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10).
PMID 11165244·FEBS Lett·2001
8-other
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.
PMID 19029963·Bone Marrow Transplant·2009
3-trial
A synthetic lectin for O-linked beta-N-acetylglucosamine.
PMID 19072969·Angew Chem Int Ed Engl·2009
8-other
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia.
PMID 18931344·Blood·2009
3-trial
Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit.
PMID 18936734·Bone Marrow Transplant·2009
8-other
Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth.
PMID 19208780·J Mol Endocrinol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 353 CASH RD SW
CAMDEN, AR 71701 - Phone
- (870) 836-8101
Quick Facts
- NPI
- 1578530366
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile